Asia Pacific Hormone Replacement Therapy Market Size & Outlook

The hormone replacement therapy market in Asia Pacific is expected to reach a projected revenue of US$ 8,431.1 million by 2030. A compound annual growth rate of 7.2% is expected of Asia Pacific hormone replacement therapy market from 2023 to 2030.
Revenue, 2022 (US$M)
$4,832.2
Forecast, 2030 (US$M)
$8,431.1
CAGR, 2023 - 2030
7.2%
Report Coverage
Asia Pacific

Asia Pacific hormone replacement therapy market, 2018-2030 (US$M)

Asia

Asia Pacific hormone replacement therapy market highlights

  • The Asia Pacific hormone replacement therapy market generated a revenue of USD 4,832.2 million in 2022.
  • The market is expected to grow at a CAGR of 7.2% from 2023 to 2030.
  • In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
  • Parathyroid Hormone replacement is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2023 to 2030.


Asia Pacific data book summary

Market revenue in 2022USD 4,832.2 million
Market revenue in 2030USD 8,431.1 million
Growth rate7.2% (CAGR from 2022 to 2030)
Largest segmentEstrogen and progesterone replacement therapy
Fastest growing segmentParathyroid Hormone replacement
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEstrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement
Key market players worldwideEli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.7% of the global hormone replacement therapy market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 8,431.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormone Replacement Therapy Market Companies

Name Profile # Employees HQ Website

Asia Pacific hormone replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.


Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 53.41% in 2022. Horizon Databook has segmented the Asia Pacific hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific is an emerging market with economies such as Japan, China, India, Australia, and South Korea at the forefront. Growing incidence of diseases caused by hormonal imbalances, such as menopause, hypothyroidism, growth hormone deficiencies, and hypoparathyroidism, is projected to drive the market growth.

As per Journal of the North American Menopause Society (May 2022), the prevalence of vasomotor symptoms associated with menopause has been reported to range from 43% to 83% in women in East Asian countries. Thus, growing number of women reaching menopause is expected to drive the demand for hormone replacement therapy in the region.

Reasons to subscribe to Asia Pacific hormone replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific hormone replacement therapy market databook

  • Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific hormone replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific hormone replacement therapy market size, by country, 2018-2030 (US$M)

Asia Pacific Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)

Asia Pacific hormone replacement therapy market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more